Dihydromyricetin relieves rheumatoid arthritis symptoms and suppresses expression of pro-inflammatory cytokines via the activation of Nrf2 pathway in rheumatoid …

J Chu, X Wang, H Bi, L Li, M Ren, J Wang - International …, 2018 - Elsevier
Rheumatoid arthritis (RA) is a systemic inflammatory and autoimmune disease. In this
research, we estimated the protective effects of Dihydromyricetin (DMY) on RA induced by …

[HTML][HTML] Diffusion-weighted imaging in relation to morphology on dynamic contrast enhancement MRI: the diagnostic value of characterizing non-puerperal mastitis

L Zhang, J Hu, N Guys, J Meng, J Chu, W Zhang… - European …, 2018 - Springer
Objectives To demonstrate the value of diffusion-weighted imaging (DWI) in the characterisation
of mastitis lesions. Methods Sixty-one non-puerperal patients with pathologically …

[HTML][HTML] Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy

SH Luo, JG Chu, HE Huang, GR Zhao… - World Journal of …, 2019 - ncbi.nlm.nih.gov
BACKGROUND Transjugular intrahepatic portosystemic shunt (TIPS) is currently used for
the treatment of complications of portal hypertension. The incidence of hepatic …

[HTML][HTML] Systematic review and meta-analysis of trans-jugular intrahepatic portosystemic shunt for cirrhotic patients with portal vein thrombosis

…, J Zhou, XM Wang, S Chen, JG Chu… - World Journal of …, 2021 - ncbi.nlm.nih.gov
BACKGROUND Portal vein thrombosis (PVT) was previously a contraindication for trans-jugular
intrahepatic portosystemic shunt (TIPS). AIM To perform a systematic review and meta-…

Portosystemic shunt via the left branch of portal vein for the prevention of encephalopathy following transjugular intrahepatic portosystemic shunt

J Chu, X Sun, L Piao, Z Chen, H Huang… - Zhonghua gan Zang …, 2002 - europepmc.org
OBJECTIVE: To determine and analyze plasma ammonia concentration difference of the
portal vein system and ramifications of rabbits and consequently guide selection of the portal …

[HTML][HTML] Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma

SH Luo, JG Chu, H Huang, KC Yao - World journal of clinical cases, 2019 - ncbi.nlm.nih.gov
BACKGROUND There is a close relationship between cirrhosis and hepatocellular carcinoma
(HCC). Transjugular intrahepatic portosystemic shunt (TIPS) has good clinical effect in …

[HTML][HTML] Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications

…, MJ Cai, SL Han, XQ Zhang, JG Chu - World Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Transjugular intrahepatic portosystemic shunt (TIPS) is placed important role
in the therapy of complications of portal hypertension, there is still no suitable criterion for a …

[HTML][HTML] Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt

SH Luo, JG Chu, H Huang, KC Yao - World Journal of …, 2017 - ncbi.nlm.nih.gov
METHODS We studied 425 patients from January 2004 to January 2015 with refractory ascites
or variceal bleeding who required TIPS placement. Patients were randomly divided into …

[HTML][HTML] Incidence of portal vein thrombosis after splenectomy and its influence on transjugular intrahepatic portosystemic shunt stent patency

F Dong, SH Luo, LJ Zheng, JG Chu… - World Journal of …, 2019 - ncbi.nlm.nih.gov
BACKGROUND Transjugular intrahepatic portosystemic shunt (TIPS) is widely accepted as
an alternative to surgery for management of complications of portal hypertension. TIPS has …

[HTML][HTML] Strontium ranelate causes osteophytes overgrowth in a model of early phase osteoarthritis

JG Chu, MW Dai, Y Wang, FM Tian, HP Song… - BMC musculoskeletal …, 2017 - Springer
Background Osteoarthritis (OA) involves cartilage changes as well as modifications of
subchondral bone and synovial tissues. Strontium ranelate (SR), an anti-osteoporosis compound, …